Evidence map›Paper›PMID 24901235›Full record

ArticleBritish journal of cancer2014

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.

J Sternemalm, H G Russnes, X Zhao, B Risberg, S Nord, C Caldas, A L Børresen-Dale, T Stokke, S Patzke

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Identifies microtubule-binding proteinComputational and structural biotechnology journal · 2022
    Article
  3. Review
  4. Article
  5. Primary cilia proteins: ciliary and extraciliary sites and functions.Cellular and molecular life sciences : CMLS · 2018
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

J SternemalmDepartment of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway.
H G Russnes1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [3] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway.
X ZhaoCenter for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
B Risberg1] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Institute for Medical Informatics, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway.
S Nord1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway.
C Caldas1] Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] Cambridge Breast Unit, Addenbrooke's Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
A L Børresen-Dale1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway.
T StokkeDepartment of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway.
S PatzkeDepartment of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway.
Oslo University Hospital · NOCancer Research UK · GBCenter for Systems Biology · USUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe multi-exon CSPP1 gene, encoding for centrosome and microtubule-associated proteins involved in ciliogenesis and cell division, is a candidate oncogene in luminal breast cancer but expression of CSPP1 proteins remained unexplored.

methodsCSPP1 gene and protein expression was examined in normal mammary tissue, human breast cancer cell lines, and primary breast cancer biopsies from two patient cohorts. Cell type and epitope-dependent subcellular-specific CSPP1 staining pattern in normal mammary gland epithelium and cancer biopsies were correlated to molecular and clinical parameters.

resultsA novel, nuclear localised CSPP1 isoform was exclusively detected in luminal epithelial cells, whereas cytoplasmic CSPP-L was generally expressed in normal mammary epithelium. Luminal cell-related nuclear CSPP1 expression was preserved in type-matched cell lines and carcinomas, and correlated to gene copy number and mRNA expression. In contrast, basal-like carcinomas displayed generally lower CSPP1 mRNA expression. Yet, a subgroup of basal-like breast carcinomas depicted nuclear CSPP1 expression, displayed luminal traits, and differed from nuclear CSPP1 devoid counterparts in expression of eight genes. Eight-gene signature defined groups of basal-like tumours from an independent cohort showed significant differences in survival.

conclusionsDifferential expression of a nuclear CSPP1 isoform identified biologically and clinically distinct subgroups of basal-like breast carcinoma.

Indexed as

Breast NeoplasmsCell Culture TechniquesCell Cycle ProteinsCell Line, TumorCell NucleusEpithelial CellsFemaleGene ExpressionGene Expression ProfilingHEK293 CellsHumansImmunohistochemistryMCF-7 CellsMicrotubule-Associated ProteinsNeoplasms, Basal CellTransfectionCell Cycle ProteinsCSPP1 protein, humanMicrotubule-Associated Proteins

Identifiers

PMID24901235
PMCPMC4102947
OpenAlexW2050068050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.